T. Rowe Price US Large Cap Growth Equity Fund A USD vs Swedbank Robur Healthcare

T. Rowe Price US Large Cap Growth Equity Fund A USD vs Swedbank Robur Healthcare

1. T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Security

    T. Rowe Price US Large Cap Growth Equity Fund A USD

  • Fee

    1.59%

  • ISIN

    LU0174119429

  • Holdings

    9

2. Swedbank Robur Healthcare

  • Security

    Swedbank Robur Healthcare A

  • Fee

    1.30%

  • ISIN

    SE0000639445

  • Holdings

    25

Fund Holdings

We have information about 19 holdings in T. Rowe Price US Large Cap Growth Equity Fund A USD, where the largest holding is Microsoft (9.79), followed by Nvidia (9.77) and Apple (9.5). In comparison with Swedbank Robur Healthcare, we have 27 holdings where UnitedHealth is the largest holding (8.49), followed by Eli Lilly (8.12) and AstraZeneca (6.21).

All Holdings

Here we compare the holdings in T. Rowe Price US Large Cap Growth Equity Fund A USD and Swedbank Robur Healthcare.

T. Rowe Price US Large Cap Growth Equity Fund A USD Swedbank Robur Healthcare
1. Microsoft Corp
USA
9.79 %
1. UnitedHealth Group Inc
USA
8.49 %
2. Nvidia Corp
USA
9.77 %
2. Eli Lilly and Co
USA
8.12 %
3. Apple Inc
USA
9.5 %
3. AstraZeneca
Sweden UK
6.21 %
4. Amazon.com Inc
USA
6.32 %
4. Novo Nordisk B
Denmark
5.78 %
5. Alphabet Inc Class A
USA
4.72 %
5. AbbVie Inc
USA
5.01 %
6. Meta Platforms A
USA
4.69 %
6. Merck & Co Inc
Germany
4.71 %
7. Broadcom Inc
USA
3.93 %
7. Thermo Fisher Scientific Inc
4.45 %
8. Mastercard Inc
USA
3.54 %
8. McKesson Corp
USA
4.27 %
9. Intuit Inc
3.24 %
9. Abbott Laboratories
USA
4.24 %
- 10. Danaher Corp
USA
4.03 %
- 11. Roche Holding AG
Switzerland
3.84 %
- 12. Boston Scientific Corp
3.73 %
- 13. Centene Corp
3.56 %
- 14. Vertex Pharmaceuticals Inc
3.28 %
- 15. Sanofi SA
France
2.96 %
- 16. HCA Healthcare Inc
2.76 %
- 17. Merck KGaA
Germany
2.19 %
- 18. Cooper Companies Inc
1.78 %
- 19. Edwards Lifesciences Corp
1.62 %
- 20. Takeda Pharmaceutical Co Ltd
Japan
1.55 %
- 21. Hologic Inc
1.43 %
- 22. IQVIA Inc
1.36 %
- 23. Royalty Pharma Plc
1.36 %
- 24. Halozyme Therapeutics Inc
0.91 %
- 25. ConvaTec Group Plc
0.83 %

The list of fund holdings was last updated on September 10, 2025.